173 related articles for article (PubMed ID: 27716071)
1. Effectiveness of cyclosporine as a treatment for steroid-resistant Cronkhite-Canada syndrome; two case reports.
Yamakawa K; Yoshino T; Watanabe K; Kawano K; Kurita A; Matsuzaki N; Yuba Y; Yazumi S
BMC Gastroenterol; 2016 Oct; 16(1):123. PubMed ID: 27716071
[TBL] [Abstract][Full Text] [Related]
2. Steroid-resistant Cronkhite-Canada syndrome successfully treated by cyclosporine and azathioprine.
Ohmiya N; Nakamura M; Yamamura T; Yamada K; Nagura A; Yoshimura T; Hirooka Y; Matsumoto T; Hirata I; Goto H
J Clin Gastroenterol; 2014; 48(5):463-4. PubMed ID: 24172181
[No Abstract] [Full Text] [Related]
3. Cronkhite-Canada Syndrome Associated with Gastric Outlet Obstruction and Membranous Nephropathy: A Case Report and Review of the Literature.
Onozato Y; Sasaki Y; Abe Y; Yaoita T; Yagi M; Mizumoto N; Shoji M; Kon T; Sakai T; Ueno Y
Intern Med; 2020 Nov; 59(22):2871-2877. PubMed ID: 32669505
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic features and treatment outcomes in Cronkhite-Canada syndrome: support for autoimmunity.
Sweetser S; Ahlquist DA; Osborn NK; Sanderson SO; Smyrk TC; Chari ST; Boardman LA
Dig Dis Sci; 2012 Feb; 57(2):496-502. PubMed ID: 21881972
[TBL] [Abstract][Full Text] [Related]
5. Case report of patient with a Cronkhite-Canada syndrome: sustained remission after treatment with corticosteroids and mesalazine.
Schulte S; Kütting F; Mertens J; Kaufmann T; Drebber U; Nierhoff D; Töx U; Steffen HM
BMC Gastroenterol; 2019 Feb; 19(1):36. PubMed ID: 30813906
[TBL] [Abstract][Full Text] [Related]
6. A case of recurrent Cronkhite-Canada syndrome containing colon cancer.
Zhu X; Shi H; Zhou X; Zong Y; Wang J; Xiao J; Zhang Y; Tian Y
Int Surg; 2015 Mar; 100(3):402-7. PubMed ID: 25785317
[TBL] [Abstract][Full Text] [Related]
7. Cases Report the Cronkhite-Canada Syndrome: Improving the Prognosis.
Yu YQ; Whorwell PJ; Wang LH; Li JX; Chang Q; Meng J
Medicine (Baltimore); 2015 Dec; 94(52):e2356. PubMed ID: 26717374
[TBL] [Abstract][Full Text] [Related]
8. Clinical and Endoscopic Response to Anti-Tumor Necrosis Factor-Alpha Antibody Therapy in a Patient With Cronkhite-Canada Syndrome.
Salman Roghani R; De Castro J; Ajumobi AB
J Investig Med High Impact Case Rep; 2023; 11():23247096231179451. PubMed ID: 37278538
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic and clinical evaluation of treatment and prognosis of Cronkhite-Canada syndrome: a Japanese nationwide survey.
Watanabe C; Komoto S; Tomita K; Hokari R; Tanaka M; Hirata I; Hibi T; Kaunitz JD; Miura S
J Gastroenterol; 2016 Apr; 51(4):327-36. PubMed ID: 26216651
[TBL] [Abstract][Full Text] [Related]
10. Sustained remission of Cronkhite-Canada syndrome after corticosteroid and mesalazine treatment: A case report.
Chen YL; Wang RY; Mei L; Duan R
World J Clin Cases; 2024 May; 12(14):2431-2437. PubMed ID: 38765740
[TBL] [Abstract][Full Text] [Related]
11. Cronkhite-Canada syndrome associated with esophageal and gastric cancers: report of a case.
Ito M; Matsumoto S; Takayama T; Wakatsuki K; Tanaka T; Migita K; Nakajima Y
Surg Today; 2015 Jun; 45(6):777-82. PubMed ID: 25008327
[TBL] [Abstract][Full Text] [Related]
12. A case of Cronkhite-Canada syndrome with repeated linked color imaging observation of the subepithelial capillary network in the colon.
Matsumoto Y; Koyama F; Morita K; Kuge H; Obara S; Iwasa Y; Takei T; Sadamitsu T; Ohbayashi C; Sho M
Clin J Gastroenterol; 2022 Oct; 15(5):934-940. PubMed ID: 35864388
[TBL] [Abstract][Full Text] [Related]
13. Recombinant Thrombomodulin Used to Successfully Treat Cronkhite-Canada Syndrome with Disseminated Intravascular Coagulation due to Sepsis in a Compromised Patient.
Morino K; Honma Y; Kumei S; Watanabe T; Kume K; Yoshikawa I; Harada M
Intern Med; 2018 Nov; 57(21):3079-3085. PubMed ID: 29877275
[TBL] [Abstract][Full Text] [Related]
14. Nail Matrix Pathology in Cronkhite-Canada Syndrome: The First Case Report.
Chuamanochan M; Tovanabutra N; Mahanupab P; Kongkarnka S; Chiewchanvit S
Am J Dermatopathol; 2017 Nov; 39(11):860-862. PubMed ID: 29058694
[TBL] [Abstract][Full Text] [Related]
15. Sustained clinical response to infliximab in refractory Cronkhite-Canada syndrome.
Jiang CD; Myint H; Tie A; Stace NH
BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33370944
[TBL] [Abstract][Full Text] [Related]
16. Cronkhite-Canada syndrome: treatment responses and improved overall survival.
Pham JT; Kisiel JB; Sweetser S
Int J Colorectal Dis; 2023 Feb; 38(1):39. PubMed ID: 36781513
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporine in the treatment of severe attack of ulcerative colitis: a systematic review.
García-López S; Gomollón-García F; Pérez-Gisbert J
Gastroenterol Hepatol; 2005 Dec; 28(10):607-14. PubMed ID: 16373009
[TBL] [Abstract][Full Text] [Related]
18. [Cronkhite-Canada syndrome: an acquired, potentially reversible polyposis].
Marín Serrano E; Guillén Mariscal P; Pérez-Requena J; Rendón Unceta P
Gastroenterol Hepatol; 2006 Dec; 29(10):619-21. PubMed ID: 17198639
[TBL] [Abstract][Full Text] [Related]
19. A Case Report of Cronkhite-Canada Syndrome Complicated by Membranous Nephropathy.
Firth C; Harris LA; Smith ML; Thomas LF
Case Rep Nephrol Dial; 2018; 8(3):261-267. PubMed ID: 30643792
[TBL] [Abstract][Full Text] [Related]
20. Case report-malignant transformation in Cronkhite-Canada syndrome polyp.
Zong Y; Zhao H; Yu L; Ji M; Wu Y; Zhang S
Medicine (Baltimore); 2017 Feb; 96(6):e6051. PubMed ID: 28178153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
